To assess ARIA incidence, amyloid clearance and clinical outcomes in a real-world cohort of patients with Alzheimer disease (AD) undergoing amyloid-targeted therapy (ATT) in a memory clinic.
No takes yet. Share an insight, caveat, or question.
Olson et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: